Martyn Jacobs
Stock Analyst at Bell Potter
(0.05)
# 4,868
Out of 5,134 analysts
223
Total ratings
16.9%
Success rate
-19.3%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: AYA Artrya Limited | Reiterated: Buy | $4.30 → $5.20 | $3.17 | +64.30% | 9 | Nov 15, 2026 | |
| ASX: EBR EBR Systems, Inc. | Reiterated: Buy | $0.20 → $0.30 | $0.16 | +93.55% | 23 | Nov 10, 2026 | |
| ASX: PHX Pharmx Technologies Limited | Reiterated: Buy | $0.20 | $0.07 | +198.51% | 1 | Nov 10, 2026 | |
| ASX: LDX Lumos Diagnostics Holdings Limited | Reiterated: Buy | $0.20 | $0.07 | +185.71% | 6 | Nov 9, 2026 | |
| ASX: IPD ImpediMed Limited | Reiterated: Buy | $0.01 | $0.00 | +150.00% | 17 | Nov 1, 2026 | |
| ASX: IDX Integral Diagnostics Limited | Reiterated: Buy | $3.15 → $2.70 | $1.66 | +62.65% | 10 | Oct 29, 2026 | |
| ASX: VFY Vitrafy Life Sciences Limited | Reiterated: Buy | $5.15 → $4.85 | $2.40 | +102.08% | 13 | Oct 29, 2026 | |
| ASX: ONE Oneview Healthcare PLC | Reiterated: Buy | $0.42 → $0.30 | $0.14 | +114.29% | 12 | Oct 27, 2026 | |
| ASX: BIO Biome Australia Limited | Reiterated: Buy | $0.75 | $0.37 | +102.70% | 21 | Oct 26, 2026 | |
| ASX: EMV EMVision Medical Devices Ltd | Reiterated: Buy | $3.15 | $1.43 | +121.05% | 11 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.45 → $0.50 | $0.28 | +81.82% | 6 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.00 | $0.43 | +132.56% | 17 | Oct 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.77 → $0.75 | $0.75 | - | 9 | Aug 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $0.75 → $0.50 | $0.26 | +92.31% | 16 | Aug 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28.75 → $27.50 | $19.84 | +38.64% | 7 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.008 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.012 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.036 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.30 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.83 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.069 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.045 | n/a | 7 | Oct 31, 2022 |
Artrya Limited
Nov 15, 2026
Reiterated: Buy
Price Target: $4.30 → $5.20
Current: $3.17
Upside: +64.30%
EBR Systems, Inc.
Nov 10, 2026
Reiterated: Buy
Price Target: $0.20 → $0.30
Current: $0.16
Upside: +93.55%
Pharmx Technologies Limited
Nov 10, 2026
Reiterated: Buy
Price Target: $0.20
Current: $0.07
Upside: +198.51%
Lumos Diagnostics Holdings Limited
Nov 9, 2026
Reiterated: Buy
Price Target: $0.20
Current: $0.07
Upside: +185.71%
ImpediMed Limited
Nov 1, 2026
Reiterated: Buy
Price Target: $0.01
Current: $0.00
Upside: +150.00%
Integral Diagnostics Limited
Oct 29, 2026
Reiterated: Buy
Price Target: $3.15 → $2.70
Current: $1.66
Upside: +62.65%
Vitrafy Life Sciences Limited
Oct 29, 2026
Reiterated: Buy
Price Target: $5.15 → $4.85
Current: $2.40
Upside: +102.08%
Oneview Healthcare PLC
Oct 27, 2026
Reiterated: Buy
Price Target: $0.42 → $0.30
Current: $0.14
Upside: +114.29%
Biome Australia Limited
Oct 26, 2026
Reiterated: Buy
Price Target: $0.75
Current: $0.37
Upside: +102.70%
EMVision Medical Devices Ltd
Oct 26, 2026
Reiterated: Buy
Price Target: $3.15
Current: $1.43
Upside: +121.05%
Oct 20, 2026
Reiterated: Buy
Price Target: $0.45 → $0.50
Current: $0.28
Upside: +81.82%
Oct 15, 2026
Reiterated: Buy
Price Target: $1.00
Current: $0.43
Upside: +132.56%
Aug 31, 2026
Reiterated: Hold
Price Target: $0.77 → $0.75
Current: $0.75
Upside: -
Aug 28, 2026
Reiterated: Buy
Price Target: $0.75 → $0.50
Current: $0.26
Upside: +92.31%
Aug 20, 2026
Reiterated: Buy
Price Target: $28.75 → $27.50
Current: $19.84
Upside: +38.64%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.008
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.012
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.036
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.30
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $2.83
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.069
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.045
Upside: n/a